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 Original Article 
Femoral Vein Transposition Arteriovenous Fistula 
is a Feasible Option in “Selected” Patients as 
Hemodialysis Access
Zia Ur Rehman, MBBS, FCPS, ChM Vascular and Endovascular Surgery, Asa Arham, MBBS, 
and Ziad Sophie, MD
Introduction: Lower extremity hemodialysis access is of-
fered to the patients who have severe central venous ste-
nosis. Femoral vein transposition arteriovenous fistula (FV 
tAVF) is an alternative to lower leg arteriovenous prosthetic 
grafts. Its safety and patency is under observation.
Materials and Methods: This is a retrospective review of 
patients who had FV tAVF between January 2011 and March 
2016. Preoperative clinical findings, intraoperative findings, 
postoperative complications, and patency of the AVF were 
noted and analyzed.
Results: There were 7 patients who underwent FV tAVF 
during this study period. Most patients were female (6 : 1), 
with mean age of 45.2 years (range, 33–55 years). All 
patients were hypertensive. Mean body mass index was 
26.1 kg/m2. Patient had on average previous 6 dialysis ac-
cesses. Most patients had preoperative venograms (6/7). 
Mean interval between initiation of dialysis and creation of 
the arteriovenous fistula was 1.08 years. All procedures were 
done under general anesthesia. Four patients required ex-
tension of FV with either the small segment of polytetrafluo-
rethylene or vein graft. Two patients had early postoperative 
complications. One patient developed hematoma, whereas 
other had wound dehiscence. All the accesses were utilized 
for dialysis after a mean interval of 6 weeks. All patients had 
a patent fistula on average follow-up of 2 years.
Conclusion: Appropriate patient selection for FV tAVF can 
provide good patency with low incidence of complications. 
This can be considered for good risk individuals undergoing 
their first lower extremity access.
Keywords: lower extremity, arteriovenous access, hemodi-
alysis
Introduction
In patients requiring hemodialysis, the upper limb is the 
preferred choice for access creation. Unfortunately, due 
to lack of an optimal health care system in Pakistan, most 
of the patients for hemodialysis access present late. These 
patients have central catheters in place.  Their forearm 
veins have already been exhausted due to multiple veni-
punctures or previously failed hemodialysis accesses. They 
develop central venous stenosis quite earlier. The lower 
limb is the next option for creating a dialysis access in 
patients who have bilateral upper arms central stenosis.
Lower leg prosthetic grafts are reported with a higher 
incidence of graft and wound infection. Patency is lower 
because of the early formation of neointimal hyperplasia 
at the graft-venous anastomosis. They are also associated 
with higher risk of steal syndrome. One option in the 
lower extremity is creation of arteriovenous (AV) access 
using the great saphenous vein. This has not shown good 
results, likely related to its thick wall and multiple valves 
acting as a nidus for neointimal hyperplasia. Reports on 
saphenous vein superficialization demonstrated poor re-
sults.1)
The femoral vein (FV) is good conduit for creating an 
AV access. It has proved useful in a variety of settings 
favoring a large venous conduit.2–4) It has a thin wall con-
taining fewer valves compared with the great saphenous 
vein. FV has been utilized as an autogenous fistula in 
various centers with acceptable results. The primary and 
secondary patency for this access has been documented as 
91% and 84%5) at one year.
The FV is deep seated and has multiple tributaries. It 
requires extensive dissection for harvesting. Patients on 
long-term hemodialysis are already nutritionally depleted 
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and are expected to have higher wound-related issues 
compared with the normal population. There are many 
studies mentioning increased incidence of steal syndrome 
and wound-related complications with this procedure, 
raising safety concerns for this procedure.6,7)
The aim of this study was to determine patency rate and 
the complications in patients undergoing FV transposition 
arteriovenous fistula (FV tAVF) at our institute.
Materials and Methods
This is a retrospective case series. It included patients from 
January 2011 to March 2016. All those patients who 
underwent FV tAVF were included in this study. Patients 
with incomplete follow-up or records were excluded from 
the study. The study was approved by the institutional 
ethical review committee (3162-Sug-ERC-14). The data of 
patients were retrieved from the hospital database using 
International Classification of Diseases coding system. 
Designed proforma was filled. Data related to patient 
demographics, comorbidities, preoperative clinical find-
ings especially arterial and venous systems of the lower 
extremity, intraoperative findings, and postoperative com-
plications were noted. Patients’ files were also reviewed for 
follow-up visits to evaluate patency of access. Complica-
tions such as AV access thrombosis, wound dehiscence, 
hematoma formation, and leg ischemia were also noted.
At our institute, we prefer upper extremity accesses. Pa-
tients are initially evaluated for radiocephalic or brachio-
cephalic arteriovenous fistulae. These are our first choices. 
If both options are not available, patients are evaluated 
for basilic transposition arteriovenous fistula either in 
the forearm or most commonly in the upper arm. If both 
basilic veins are not available, patients are considered for 
forearm or upper arm prosthetic grafts. Patients are also 
considered for axillo-axillary arteriovenous grafts before 
offering lower extremity accesses. Our preference in the 
lower leg is more for FV tAVF than the prosthetic grafts.
In this case series, those patients were included who 
had exhausted upper arm veins and have bilateral upper 
arm central venous stenosis. All patients had preoperative 
bilateral upper extremity venogram to check for central 
venous stenosis. Preoperative venous mapping of lower 
extremity veins were also performed in all patients. Pa-
tients with the previous history of deep venous thrombosis 
were not offered this operation. Same was true if they 
had arterial insufficiency. Specific history for intermittent 
claudication and detailed peripheral arterial examina-
tion was done. Only patients with no history of arterial 
insufficiency and palpable ankle pulses were offered this 
procedure. Preoperative venogram of lower extremity 
was also performed to rule out if the patient had a history 
of femoral cannulation. This is to rule out iliac venous 
stenosis. The surgery followed the technique described by 
Gradman et al. in 20018) and 2005.9) A longitudinal inci-
sion from the inguinal crease to just above the knee was 
made to harvest the FV. After division of subcutaneous 
tissue, the sartorius muscle was identified. This was well 
mobilized to havest underlying vein. Care was taken to 
preserve as many femoral artery branches as possible. Vein 
tributaries were double ligated. The vein was dissected 
free from its junction to the profunda femoris vein proxi-
mally to beyond the adductor hiatus distally. The length 
of the vein harvested depended on the size of the patient: 
thinner patients required lesser vein than obese patients. 
A subcutaneous tunnel was created in the anterolateral 
thigh. The vein was later placed  in this tunnel. The vein 
was transposed superficially and anastomosed to the distal 
femoral artery. Tapering of the vein was done in patients 
when there was a discrepancy between the diameter of the 
FV and the artery. If required, a small segment of the pros-
thetic graft was used to obtain an appropriate size of the 
vein. Same was the approach if the length of the dissected 
vein became inadequate for making the anastomosis com-
fortably. This does happen in patients having relatively 
thick subcutaneous tissue. The wounds were closed in two 
layers over a suction drain. Patients were closely observed 
for immediate postoperative complications especially steal 
syndrome, bleeding, graft thrombosis, or venous insuf-
ficiency. They were kept inpatient and discharged when 
fully mobilized and stable. Patients were followed in the 
clinic after 1 week to evaluate fistula patency and to detect 
wound-related complications. If everything is fine, pa-
tients were followed after 5 weeks to check the maturation 
of access. If matured, accesses were allowed for cannula-
tion. Patients were followed after every 6 months and then 
annually. This is to detect any developing complications 
and needling issue.
Data were entered and analyzed using SPSS version 19. 
Quantitative variables were reported as mean ± standard 
deviation, or median with interquartile ranges, depending 
upon the distribution of the data. Qualitative variables 
were reported and expressed as proportion and percent-
age of patients.
Results
Seven patients underwent FV tAVF during this study peri-
od. Most of the patients were female (6 : 1). Mean age was 
45.2 years (range, 33–55 years). All patients were hyper-
tensive (Table 1). The mean interval between the initiation 
of dialysis and creation of the FV tAVF was 1.08 years. 
Six patients had venogram to rule out any stenosis in the 
iliac veins preoperatively. Particulars related to American 
Society of Anesthesiologists type, type of anesthesia and 
types of the incision are given in Table 2.
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Two patients developed postoperative complications 
(Table 3). One patient developed hematoma and did re-
quired exploration to evacuate it. She was on therapeutic 
oral anticoagulation, which was stopped before the opera-
tion. Perioperatively, there was no active bleeding point 
identified. One patient had wound dehiscence, which 
required washout and partial closure of the wound. All 
the patent accesses were utilized for dialysis after a mean 
interval of 6 weeks. One patient developed central venous 
stenosis 6 months later and underwent iliac vein stenting. 
All the patent accesses were utilized for dialysis after a 
mean interval of 6 weeks. All patients had a patent fistula 
on average follow-up of 2 years. Primary patency was 
85%, and primary-assisted patency was 100% (Table 4).
Discussion
Patients who have exhausted upper extremity veins or 
have developed central venous stenosis require an alter-
nate site for hemodialysis access creation.10) The alternate 
choice can be the lower limbs where a graft or an autog-
enous fistula can be formed. Autogenous access can be 
created using either the great saphenous vein (GSV) or 
the FV. Prosthetic grafts are inferior as they have a higher 
incidence of infection11) and lesser patency compared with 
autogenous access. In one series of 45 patients using either 
polytetrafluoroethylene (PTFE) (n=39) or bovine graft 
(n=6), the 2 year primary patency rate was 47% with 
an infection rate of 18%.12) Unfortunately, GSV also has 
shown poor patency.13,14) This is likely due to its relatively 
thick wall and reduced chances of maturation.
In this study, there was 1 patient who had a major 
wound dehiscence requiring formal washout and partial 
closure of the wound. Fortunately, the anastomosis was 
well protected by the overlying sartorius muscle. The pa-
tient had a usable fistula after 6 weeks.
To decrease wound-related complications, skip incision 
technique is also advocated. In 1 patient in the latter half 
of the series, skip incision technique was used instead 
of a longitudinal incision. Alcocer et al. showed wound 
morbidity can be reduced by using small skin incision 
technique. They compared a cohort of 12 patients with 
FV tAVF created with standard technique versus 13 pa-
tients with FV tAVF created with modified small incision 
technique. By modified technique, they mean small about 
12 cm mid-thigh incision. In the standard technique, 5 
patients had wound-related complications, whereas no 
patient had a wound-related complication in the modified 
group. Patency was similar in both groups.15)
Another problem is size discrepancy between the FV 
which is usually more than 10 mm and the superficial 
femoral artery. Creating a wider anastomosis always 
places these patients to the risk of steal syndrome. The 
Table 1 Preoperative patient characteristics
Variables N=7
Average age in years (range) 45.2 (35.0–55.0)
Females 6 (85.0%)
Diabetes mellitus 1 (14.3%)
Hypertension 7 (100%)
Ischemic heart disease 1 (14.3%)
Hypothyroid 1 (14.3%)
Hepatitis C 1 (14.3%)
Infective endocarditis 1 (14.3%)
Tuberculosis 1 (14.3%)
Mean body mass index (kg/m2) (range) 26.4 (25.0–30.0)
Previous history of femoral dialysis catheters 1 (14.3%)
Venograms of lower legs 6 (85.7%)
Mean number of dialysis accesses 6
Table 2 Perioperative details
Variables N=7
Mean ASA grade 2.85
Type of anesthesia
a. General anesthesia 7 (100%)
Type of incision
a. Standard longitudinal 6 (85.7%)
b. Skip incision 1 (14.3%)
Extension of FV by
a. Prosthetic (PTFE) graft 3 (42.8%)
b. Autologous (GSV) graft 1 (14.3%)
ASA: American Society of Anesthesiologists; FV: femoral vein; 
PTFE: polytetrafluoroethylene; GSV: great saphenous vein




Steal syndrome requiring intervention 0
Venous swelling requiring fasciotomy 0
Iliac vein angioplasty/stenting 1
Table 4 Follow-up of patients
Patient 
no.






1 1 Yes —
2 3 Yes Iliac vein angioplasty
Iliac vein stenting
3 3 Yes —
4 2.5 Yes —
5 2 Yes —
6 1 Yes —
7 1 Yes —
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presence of arterial occlusive disease in the lower extrem-
ity also contributes to these patients for developing steal 
syndrome. Fortunately, none of our patients developed 
severe steal. When FV tAVF was first described in 2001, 
there was initially a higher incidence of lower extremity 
ischemia. This complication was subsequently resolved 
by improved technique (tapered FV, distal femoral artery 
pressure measurement, and fasciotomy) and improved 
patient selection (avoiding surgery in patients with a sig-
nificant occlusive disease).
Preoperatively, all patients had normal arterial sup-
ply with palpable ankle pulses. Anastomoses were not 
more than 5–6 mm in size. It was made possible by either 
tapering the vein end or using a small piece of PTFE as 
interposition graft. In order to get an adequate length in 1 
patient, a small segment of reversed GSV was used, usually 
harvested from the same wound.
Patients were followed for any fistula failure or central 
venous stenosis. One patient developed limb swelling. This 
was due to progressive iliac vein stenosis. Although she 
was initially treated with balloon angioplasty, it recurred, 
later treated with self-expanding stent. Although there is 
potential for significant venous morbidity, Wells et al. have 
reported fairly minimal long-term venous morbidity using 
sophisticated venous imaging.16) No patient developed 
significant venous swelling in this study. Sidawy et al. em-
phasized that venous obstructive complications can range 
from mild distal edema to compartment syndrome.17) 
These complications can be minimized when harvesting of 
the vein is limited to the anatomical segment proximal to 
the popliteal vein.
The flow rate in FV tAVF is higher than the upper arm 
accesses. There is always a risk that they may develop 
signs of heart failure. At the 2 years follow-up, fortu-
nately no patient developed signs or symptoms of heart 
failure. Jackson pointed out that flow rates in two of his 
reported patients with FV tAVF were substantially higher 
(2000 mL/min) than generally observed in upper-arm 
grafts, but congestive heart failure did not develop in ei-
ther patient.18)
Patients with peripheral vascular disease and cardiac 
failure are not good candidates for this procedure. One 
has to be very careful in selecting patients for FV tAVF.
Conclusion
Although FV tAVF is associated with significant wound-
related and ischemic complications, we have found in this 
study that careful selection of patients can lead to a favor-
able outcome. We suggest that FV tAVF be considered in 
“selected” patients as an alternative before the lower leg 
prosthetic grafts.
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